Evaluation of the role of vitamin d in reducing the severity and duration of hospitalization of rotavirus infection in Iraqi children

Comparison of the Effectiveness of adding vitamin d with standard treatment in reducing the severity and duration of hospitalization of rotavirus infection in Iraqi children

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250115064393N1

Enrollment

Registered

2025-01-30

Start date

2025-02-01

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotaviral enteritis. Rotaviral enteritis

Interventions

Intervention 1: Intervention group: will receive vitamin D single oral dose 300000 IU ampul for age 1 year in addition to standard treatment. Intervention 2: Control group: will receive standard trea

Eligibility

Sex/Gender

All

Age

5 Months to 2 Years

Inclusion criteria

Inclusion criteria: Children with age from 5 months to 2 years with confirmed rotavirus infection by rotavirus stool examination Serum vitamin D levels indicating deficiency (below 20 ng/mL)(27).

Exclusion criteria

Exclusion criteria: Children with other major infections, severe dehydration or underlying health conditions. Children with current vitamin D supplementation

Design outcomes

Primary

Measure	Time frame
Severity of gastroenteritis. Timepoint: 7 days. Method of measurement: Vasikari scoring system.	—

Secondary

Measure	Time frame
C reactive protein and complete blood count. Timepoint: After 3 days and 7 days. Method of measurement: Lab kit.	—

Countries

Iraq

Contacts

Public ContactFadia Thamir Ahmed

Baghdad university

fadia.ahmed@copharm.uobaghdad.edu.iq+964 770 393 0077

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026